Ignite Creation Date:
2024-05-06 @ 3:58 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04826172
Status:
COMPLETED
Last Update Posted:
2024-04-23
First Post:
2021-03-18
Brief Title:
Exploratory Study on the Safety Tolerability and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease IMPROVE-Ischemia
Sponsor:
Imbria Pharmaceuticals Inc
Organization:
Imbria Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-18
First Submit QC Date:
March 29 2021
Study First Post Date:
2021-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL